RT Journal Article
SR Electronic
T1 PROGNOSTIC FACTORS FOR CLINICAL COURSE OF PATIENTS WITH COVID-19: PROTOCOL FOR A RAPID LIVING SYSTEMATIC REVIEW
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.06.20087692
DO 10.1101/2020.05.06.20087692
A1 Rocha-Filho, César Ramos
A1 Pinto, Ana Carolina Pereira Nunes
A1 Rocha, Aline Pereira da
A1 Milby, Keilla Martins
A1 de Assis Reis, Felipe Sebastião
A1 Civile, Vinicius Tassoni
A1 Junior, Nelson Carvas
A1 Santos, Rodolfo Rodrigo Pereira
A1 Ramalho, Gabriel Sodré
A1 Trevisani, Giulia Fernandes Moça
A1 Ferla, Laura Jantsch
A1 Puga, Maria Eduarda dos Santos
A1 Trevisani, Virgínia Fernandes Moça
A1 Atallah, Alvaro Nagib
YR 2020
UL http://medrxiv.org/content/early/2020/05/09/2020.05.06.20087692.abstract
AB CONTEXT AND OBJECTIVE Determining prognostic factors in a context of health crises such as the COVID-19 scenario may provide the best possible care for patients and optimize the management and the resource utilization of the health system. Thus, we aim to systematically review the prognostic factors for different outcomes of patients with COVID-19. DESIGN AND SETTING: Protocol for a rapid living systematic review methodology following the recommendations proposed by the Cochrane Handbook. METHODS: We will include cohorts and case-control studies. We will search Medline via PubMed, Embase via Elsevier, Cochrane Library - Cochrane Central Register of Controlled Trials (CENTRAL), Portal Regional BVS-LILACS, Scopus and WebofScience to identify studies. No language restrictions will be applied. We will perform the critical appraisal of included studies with the Quality in Prognosis Studies (QUIPS) tool and the certainty of evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE).Competing Interest StatementThe authors have declared no competing interest.Clinical TrialCRD42020183437Funding StatementThis study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES)- Finance Code 001Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article